The first total synthesis of (ϩ)-sulfamisterin (AB5366), a naturally occurring a -substituted a -amino acid derivative possessing a sulfonated hydroxy function, is described. Overman rearrangement of an allylic trichloroacetimidate derived from D-tartrate effectively generated the tetrasubstituted carbon containing a nitrogen substituent. Construction of the amino acid moiety and sulfonation of the hydroxy group, followed by deprotection completed the total synthesis, which fully confirmed the proposed absolute structure of the natural product. The possible stereoisomers of (ϩ)-sulfamisterin and their desulfonated derivatives were also synthesized. Biological assessment of all synthetic compounds revealed that natural (ϩ)-sulfamisterin and its 3-epimer as well as their desulfonated derivatives possessing 2S-configuration strongly inhibit the serine palmitoyl transferase both in vitro and in vivo, whereas compounds with 2R-configuration were found to show much weaker inhibitory activity.
Introduction
(ϩ)-Sulfamisterin (AB5366 1) is an antifungal agent isolated from the culture broths of Pycnidiella sp. AB5366 in 1996 [1, 2] and reported to be an inhibitor of serine palmitoyl transferase (SPT) [3] . The structural study by spectral and X-ray crystallographic analysis showed that 1 has an a -substituted a -amino acid structure with a sulfonated hydroxy function [2] (Fig. 1) . Compound 1 has a structure that resembles myriocin [4, 5] , a well-known SPT inhibitor as well as strong immunosuppressant. Recently, detailed SPT inhibitory activities of sulfamisterin and its simple analogues obtained by chemical transformation of the natural product have been reported [3] . With interest in the structure-activity relationship of sulfamisterin, we embarked on the synthesis of 1 and its possible stereoisomers (2ϳ4). In this paper, we report the first total synthesis of 1 and its stereoisomers (2ϳ4) as well as their desulfonated analogues (5ϳ8) starting from tartrates using Overman rearrangement [6, 7] as the key transformation. SPT inhibitory activities both in vitro and in vivo of these compounds (1ϳ8) are also reported.
Results and Discussion

Total Synthesis of (؉)-Sulfamisterin and its C-3 Epimer
The known (2S,3S)-3-benzyloxybutane-1,2,4-triol [8] (9a) derived from diisopropyl D-tartrate in 2 step reaction, was treated with 2-methoxypropene in the presence of pyridinium p-toluenesulfonate (PPTS) to afford a mixture
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of the known acetonides [9] 10a, 11a and 12a (Scheme 1). Separation of the mixture by a silica gel chromatography afforded 10a in 27% isolated yield along with a mixture of 11a and 12a (68% yield). Acid hydrolysis of a mixture of 11a and 12a gave the starting triol 9a in 87% yield, which could be reused to provide additional amount of 10a. Swern oxidation of 10a gave an aldehyde, which without purification, was reacted with Wittig reagent generated from phosphonium salt [10] 13 and n-BuLi to give 14a in 45% yield from 10a as a mixture of geometrical isomers (E : Zϭca. 1 : 4). Catalytic hydrogenation of 14a afforded saturated alcohol 15a in 88% yield. The observed coupling constants in 15a (J 4, 5 and J 5,6 Ͻ3.5 Hz) revealed the cis relationship of C-4 and C-5 substituents, supporting the assigned structure. PCC oxidation of 15a followed by reaction with Ph 3 PϭCHCO 2 Et gave 16a as a single isomer in 97% yield. The observed NOE between a vinyl proton and H-4 clearly suggested the E-geometry of the double bond. Diisobutylaluminum hydride (Dibal) reduction of 16a afforded allyl alcohol 17a in 95% yield.
With the allylic alcohol 17a in hand, we then examined the Overman rearrangement. Thus, an o-xylene solution of allylic trichloroacetimidate 18a prepared from 17a by the action of CCl 3 CN and 1,8-diazabicyclo [5.4 .0]undec-7-ene (DBU) was heated at 140°C in a sealed tube under argon in the presence of solid potassium carbonate [11] to afford the diastereomeric rearranged products, which were easily and cleanly separated by silica gel chromatography to provide 19a and 20a in 50 and 45% isolated yields, respectively. HPLC analysis of 20a and 20b (prepared from dimethyl Ltartrate, vide infra) with chiral column (chiralcel OD) showed that the optical purities of 20a and 20b are both Ͼ99% ee, respectively, indicating no racemization had occurred during the transformation of 15a to 19a and 20a. The protecting group of nitrogen (N-trichloroacetyl group) in 19a was converted into N-benzyloxycarbonyl (Cbz) group by two step reactions to give 21a, quantitatively. Similar treatment of 20a afforded 22a (97% yield). NOE experiments of 21a and 22a clearly showed that the tetrasubstituted carbon in 21a possessed S configuration whereas that in 22a is R configuration, respectively. Ozonolysis of 21a, followed by further oxidation and esterification, and subsequent acid hydrolysis afforded diol 23a in 50% yield (Scheme 2). The primary hydroxy group in 23a was selectively protected as a benzyloxymethyl ether to give 24a (64% yield), whose remaining hydroxy group was sulfonated by the action of SO 3 -pyridine [12] to afford 25a, quantitatively. Hydrogenolysis of 25a in the presence , measured in our laboratory}. Therefore, total synthesis of (ϩ)-sulfamisterin has been accomplished, confirming the proposed absolute structure of the natural product.
Similar treatment of 22a as described for the preparation of 1 from 21a afforded (2R,3R)-sulfamisterin (2), a C-3 epimer of natural sulfamisterin, in 7 step reactions and in 58% overall yield from 22a.
Preparation of Sulfamisterin Analogues
To obtain information of the biological role of the sulfate function, synthesis of desulfonated analogues of sulfamisterin was carried out (Scheme 3). Thus, ozonolysis of 19a, followed by oxidation and esterification, and subsequent deprotection of an acetonide and a ketal groups by acid hydrolysis afforded 29a in 57% yield. Saponification of 29a with 12% aqueous NaOH -MeOH followed by neutralization with acidic resin (IRC-76) furnished desulfonated sulfamisterin (5) in 53% yield. Similar treatment of 20a afforded (2R,3R)-desulfonated sulfamisterin (6) .
The enantiomers of 1, 2, 5 and 6 were synthesized starting from dimethyl L-tartrate (Scheme 4). Thus, the same reaction sequences as used for preparation of 19a and 20a from diisopropyl D-tartrate were applied to dimethyl Ltartrate to give a diastereomeric pair of 19b (enantiomer of 19a) and 20b (enantiomer of 20a). By the same reactions as employed for preparation of 1 and 5 from 19a, one of rearranged product 19b was successfully transformed into (Ϫ)-sulfamisterin (3) and (2R,3S)-desulfonated sulfamisterin (7) . Similar transformation of another rearranged product 20b provided (2S,3S)-sulfamisterin (4) and (2S,3S)-desulfonated sulfamisterin (8) .
Biological Activities
The inhibitory activities of synthetic compounds against SPT were measured according to a method described previously [3] . The results were shown in Table 1 were found to be weaker than those with 2S configuration. The fact that all compounds did not inhibit the synthesis of phosphatidylethanolamine and phosphatidylserine as well as previous results [3] suggested that sulfamistein and its analogues suppress sphingolipid biosynthesis through the inhibition of SPT. These results revealed that in sulfamisterin-type compounds, 1) the 2S configuration is essential for the high SPT inhibitory activity; 2) the configuration at C-3 is not an important factor; and 3) sulfonation of a hydroxy function at C-3 does not significantly affect the activity. These findings should be important and useful for the design of new SPT inhibitors. 
2-O-Benzyl-D-threitol (9a)
To a solution of diisopropyl D-tartrate (9.0 g, 38.4 mmol) in 90 ml of benzene at room temperature were added benzaldehyde dimethyl acetal (6.35 ml, 42.3 mmol) and 10-camphorsulfonic acid (CSA, 446 mg, 1.92 mmol), and the mixture was heated at reflux for 2 days. After cooling, the reaction mixture was neutralized with Et 3 N (0.3 ml) and diluted with EtOAc. The resulting mixture was washed with water and dried. Removal of the solvent gave a residue, which was purified by column chromatography (200 g silica gel, 1/1 EtOAc/hexane as an eluent) to afford a benzylidene derivative (13.5 g, quant.) as a pale yellow syrup. To a suspension of LiAlH 4 (5.55 g, 146 mmol) in diethyl ether (80 ml) and CH 2 Cl 2 (75 ml) was added the benzylidene derivative (13.5 g, 38.4 mmol) at 0°C. After stirring at 0°C for 40 minutes, to the reaction mixture was added AlCl 3 (16.7 g, 125 mmol) in diethyl ether (80 ml) dropwise at 0°C, and the mixture was heated at reflux for 2.5 hour. After cooling to 0°C, to the mixture were added with water (20 ml), 15 wt% NaOH aq (100 ml) and water (25 ml). The insoluble material was removed by filtration through celite (THF as an eluent), and the filtrate was dried. Removal of the solvent afforded crystalline residue, which was recrystallized from benzene to give 9a ( 
3-O-Benzyl-2,4-O-isopropylidene-D-threitol (10a)
To a solution of triol 9a (2.17 g, 10.2 mmol) and pyridinium p-toluenesulfonate (PPTS, 251 mg, 1.0 mmol) in DMF (25 ml) was added dropwise 2-methoxypropene (1.6 ml, 15.3 mmol) in DMF (5 ml) at Ϫ15°C. After being stirred at Ϫ15°C for 7 hour, the resulting mixture was neutralized with Et 3 N. The reaction mixture was diluted with EtOAc and washed with brine. The organic layer was dried and concentrated to afford the residue, which was purified by flash chromatography (100 g silica gel, 1 : 3 to 2 : 1 EtOAc/hexane as an eluent) to give 10a (700 mg, 27%) as white crystals and a mixture of 11a and 12a (1.77 The mixture of 11a and 12a (1.77 g, 7.02 mmol) was dissolved in 60% aq AcOH (13 ml) at room temperature. After stirring for 32 hour, the reaction mixture was concentrated to give a residue, which was recrystallized from benzene to afford triol 9a (1.30 g, 87%) as white crystals.
(4R,5R)-5-Benzyloxy-4-[8-(2-hexyl-[1,3]dioxolan-2-yl)-oct-1-enyl]-2,2-dimethyl-[1,3]dioxane (14a)
To a solution of (COCl) 2 (2.0 mol/liter in CH 2 Cl 2 , 3.9 ml, 7.8 mmol) was added dropwise DMSO (1.11 ml, 15.6 mmol) at Ϫ78°C for 40 minutes under argon. To this mixture was added a solution of alcohol 10a (657 mg, 2.60 mmol) in CH 2 Cl 2 (16 ml) at Ϫ78°C. The reaction mixture was stirred at Ϫ78°C for 40 minutes and then treated with Et 3 N (3.26 ml, 23.4 mmol). The resulting suspension was further stirred at 0°C for 30 minutes, and then diluted with Et 2 O. The organic layer was washed with saturated NH 4 Cl aq solution and dried. Evaporation of the solvents gave crude aldehyde (720.0 mg). To a solution of phosphonium salt 13 [10] (6.22 g, 10.4 mmol) in dry THF (19 ml) was added dropwise n-butyl lithium (1.59 mol/liter in hexane, 8.50 ml, 13.5 mmol) at Ϫ78°C and the mixture was stirred for 15 minutes at room temperature. After cooling at Ϫ78°C, to the mixture was added a solution of the crude aldehyde (720 mg) in THF (9 ml) dropwise via a cannula. After stirring for 15 minutes, to the mixture was added t-BuOH (1.2 ml) and then the dark red solution was warmed to room temperature. The resulting mixture was diluted with EtOAc, and washed with saturated NH 4 Cl aq and brine, and then dried. Removal of the solvent gave a residue, which was purified by flash chromatography (70 g silica gel, EtOAc/tolueneϭ1/40 to 1/15 as an eluent) to give coupling product 14a (574 mg, 45%) as a mixtures of geometrical isomers (E : Zϭca. 
(4R,5R)-4-[8-(2-Hexyl-[1,3]dioxolan-2-yl)-octyl]-2,2-dimethyl-[1,3]dioxan-5-ol (15a)
A mixture of 14a (402 mg, 0.82 mmol) and 20% Pd(OH) 2 on activated carbon (107 mg) in THF (1.5 ml) was hydrogenated at room temperature under atmospheric pressure of H 2 for 2 hour. After addition of K 2 CO 3 (50 mg) to the mixture, the insoluble material was removed by filtration through celite (EtOAc as an eluent). The filtrate was concentrated to give a residue, which was purified by column chromatography (10 To a solution of ester 16a (374 mg, 0.80 mmol) in toluene (9.0 ml) was added dropwise DIBAL-H (1.01 mol/liter in toluene, 2.76 ml, 2.79 mmol) at Ϫ78°C under argon. After being stirred at Ϫ78°C for 30 minutes, to the solution was added acetone (2.5 ml) and stirring was further continued for 10 minutes at 0°C. To the resulting mixture was added excess Na 2 SO 4 · 10H 2 O and the mixture was stirred for 1 hour. The insoluble material was removed by filtration through celite, and the filtrate was concentrated to give a residue, which was purified by column chromatography (20 g silica gel, 1/7 to 1/3 EtOAc/hexane as an eluent) to afford allylic alcohol 17a (322 mg, 95%) To a solution of allylic alcohol 17a (508 mg, 1.19 mmol) in CH 2 Cl 2 (15 ml) were added trichloroacetonitrile (0.30 ml, 2.98 mmol) and DBU (34.8 m l, 0.233 mmol) at 0°C, and the mixture was stirred at 0°C for 2 hour. The resulting mixture was concentrated to give a residue, which was passed through a short column of silica gel (6 g, 1/10 EtOAc/hexane containing 1% Et 3 N as an eluent) to afford roughly purified imidate 18a (651 mg) as a yellow syrup. To a solution of crude 18a (651 mg) in o-xylene (65 ml) was added K 2 CO 3 (130 mg), and the mixture was heated at 140°C in a sealed tube for 89 hour under argon. The resulting mixture was concentrated to give a residue, which was purified by column chromatography (57 g silica gel, 
(4R,5S)-{4-[8-(2-Hexyl-[1,3]dioxolan-2-yl)-octyl]-2,2-dimethyl-5-vinyl-[1,3]dioxan-5-yl}-carbamic Acid Benzyl Ester (21a)
To a solution of 19a (67 mg, 0.117 mmol) in toluene (2.0 ml) was added dropwise DIBAL-H (1.01 mol/liter in toluene, 0.23 ml, 0.23 mmol) at Ϫ78°C under argon. After being stirred at Ϫ78°C for 10 minutes, to the solution was added acetone (0.5 ml) and the mixture was stirred for 10 minutes at 0°C. To the resulting mixture was added excess Na 2 SO 4 · 10H 2 O and the mixture was further stirred at 0°C for 1.5 hour. The insoluble material was removed by filtration through celite (EtOAc as an eluent) and the filtrate was concentrated to afford crude amine (62.3 mg). To a solution of the crude amine (62.3 mg) in 1,4-dioxane (2 ml) were added NaHCO 3 (79 mg, 0.94 mmol) and carbobenzoxy chloride (CbzCl, 0.13 ml, 0.94 mmol) at room temperature and the mixture was stirred for 8 hour. The resulting mixture was diluted with EtOAc and washed with brine, and dried. Removal of the solvent gave a residue, which was purified by chromatography ( 
(4R,5R)-{4-[8-(2-Hexyl-[1,3]dioxolan-2-yl)-octyl]-2,2-dimethyl-5-vinyl-[1,3]dioxan-5-yl}-carbamic Acid Benzyl Ester (22a)
By the same reaction conditions as described for the preparation of 21a from 19a, compound 20a (60 mg, 0.10 mmol) was converted to carbamate 22a (57 mg, 97% for 2 steps); colorless syrup; [ 
(2S,3R)-2-Benzyloxycarbonylamino-3-hydroxy-2-hydroxymethyl-12-oxo-octadecanoic Acid Benzyl Ester (23a)
Ozone was introduced into a solution of carbamate 21a (19 mg, 0.034 mmol) in EtOH (2 ml) at Ϫ78°C for 10 minutes. After purging of excess ozone with a stream of Ar gas, to the solution was added Me 2 S (25 ml, 0.34 mmol) and the mixture was stirred at Ϫ78°C for 1 hour. The resulting mixture was diluted with EtOAc and washed with brine, and dried. Removal of the solvent gave crude aldehyde (20 mg) as a pale yellow syrup. To a solution of the crude aldehyde in t-BuOH (0.7 ml) and water (0.7 ml) were added NaH 2 PO 4 · 2H 2 O (10.6 mg, 0.068 mmol), HOSO 2 NH 2 (9.7 mg, 0.1 mmol) and NaClO 2 (9.0 mg, 0.1 mmol) at room temperature. After stirring for 16 hour at room temperature, the reaction mixture was quenched with 20 wt% aq solution of Na 2 S 2 O 3 . The aq phase was extracted with CHCl 3 (ϫ6). The combined organic layer was washed with 20% aq solution of Na 2 S 2 O 3 , and dried. Evaporation of the solvent afforded crude carboxylic acid (22 mg) as a white solid. To a solution of the crude carboxylic acid (22 mg) in CH 2 Cl 2 (1 ml) were added WSCD (13 mg, 0.068 mmol), DMAP (2 mg, 0.017 mmol) and benzyl alcohol (7.0 m l, 0.068 mmol) at 0°C. After being stirred at room temperature for 60 hour, the mixture was diluted with EtOAc and washed with brine and dried. Removal of the solvent gave a residue, which was purified by chromatography ( 128.2, 128.3, 128.4, 128.6, 135.4, 135.9, 157.1, 170.9 , 211.9.
(2S,3R)-2-Benzyloxycarbonylamino-2-benzyloxymethoxymethyl-3-hydroxy-12-oxooctadecanoic Acid Benzyl Ester (24a)
To a solution of 23a (50 mg, 0.086 mmol) in CH 2 Cl 2 were added i-Pr 2 NEt (37.2 m l, 0.214 mmol) and BOM-Cl (59.2 ml, 0.427 mmol) at 0°C. After stirring at 35°C for 23 hour, the resulting mixture was diluted with CHCl 3 and washed with brine, and the organic layer was dried. Removal of the solvent gave a residue, which was purified by flash chromatography (8 g silica gel, 1/10 to 1/6 EtOAc/hexane as an eluent) to afford BOM ether 24a (39 mg, 64%) 
(2S,3R)-2-Benzyloxycarbonylamino-2-benzyloxymethoxymethyl-12-oxo-3-sulfooxyoctadecanoic Acid Benzyl Ester (25a)
To a solution of alcohol 24a (11 mg, 0.016 mmol) in pyridine (1 ml) was added SO 3 -pyridine complex (25 mg, 0.16 mmol) at room temperature. After stirring at 80°C for 2 hour, the reaction mixture was diluted with MeOH at room temperature. Removal of the solvent gave a residue, which was purified by flash chromatography (1 g silica gel, 1/10 MeOH/CHCl 3 as an eluent) afforded 25a (12 14.4, 23.6, 24.9, 24.9, 26.9, 30.0, 30.3, 30.3, 30.4, 30.4,  32.5, 32.8, 43.5, 67.0, 67.4, 68.5, 70.2, 81.4, 95.7, 128.6,  128.8, 129.0, 129.2, 129.3, 129.4, 129.4, 129.6, 129.7,  136.9, 138.2, 139.3, 157.0, 171.4 , 214.4.
(؉)-Sulfamisterin (1)
To a solution of 25a (12 mg, 0.016 mmol) in MeOH (1 ml) was added 20% Pd(OH) 2 on activated carbon (10 mg) at room temperature and the mixture was hydrogenated under atmospheric pressure of H 2 for 15 hour. The insoluble material was removed by filtration through celite and the filtrate was concentrated to give a residue, which was purified by a column of Sephadex LH-20 (95 ml, MeOH as an eluent). The fractions containing 1 were collected and concentrated to give a residue, which was treated with IRC-76 resin (H ϩ form). The resin was removed by filtration and the filtrate was concentrated to afford (ϩ)-sulfamisterin (1 
(2R,3R)-Sulfamisterin (3-epi-sulfamisterin) (2)
By the same reaction conditions as described for the preparation of sulfamisterin (1) Ozone was introduced into a solution of carbamate 19a (114 mg, 0.199 mmol) in MeOH (3.4 ml) at Ϫ78°C for 15 minutes. After purging of excess ozone with a stream of Ar gas, to the solution was added Me 2 S (0.15 ml, 1.99 mmol) and the mixture was stirred at Ϫ78°C for 1 hour. The resulting mixture was diluted with EtOAc and washed with brine, and dried. Removal of the solvent gave crude aldehyde (114 mg) as a yellow syrup. To a solution of the crude aldehyde in t-BuOH (1.7 ml) and water (1.7 ml) were added NaH 2 PO 4 · 2H 2 O (62.1 mg, 0.398 mmol), HOSO 2 NH 2 (58.0 mg, 0.597 mmol) and NaClO 2 (54.0 mg, 0.597 mmol) at room temperature. After stirring for 24 hour at room temperature the reaction mixture was quenched with 20 wt% aq solution of Na 2 S 2 O 3 . The aq phase was extracted with CHCl 3 (ϫ5). The combined organic layer was washed with 20 wt% aq solution of Na 2 S 2 O 3 , and dried. Removal of the solvent afforded crude carboxylic acid (125 mg) as white solids. To a solution of the crude carboxylic acid (125 mg) in MeOH/benzene (3.8 ml, 1/4) was added Me 3 SiCHN 2 (2.0 mol/liter in hexane, 0.13 ml, 0.259 mmol) at room temperature. The mixture was stirred for 13 hour at room temperature and concentrated to give a residue, which was purified by chromatography (6 g silica gel, 1/10 to 1/5 EtOAc/hexane as an eluent) to afford methyl ester (87.4 mg) as a colorless syrup. To a solution of the methyl ester (87.4 mg) in THF (2.2 ml) was added 6 N HCl aq (1.1 ml) at 0°C, and the mixture was stirred at room temperature for 5 hour. The reaction mixture was diluted with CHCl 3 and washed with brine, and dried. Removal of the solvent gave a residue, which was purified by column chromatography (6 g silila gel, 1/6 EtOAc/toluene as an eluent) to afford diol 29a (59 mg, 57% for 4 steps) as a syrup; [ 
Desulfonated Sulfamisterin (5)
To a solution of 29a (41 mg, 0.079 mmol) in MeOH (1.3 ml) was added 12 wt% aq NaOH solution (0.6 ml) at room temperature. The mixture was stirred at 50°C for 18 hour, and then neutralized with IRC-76 resin (H ϩ form).
The resin was removed by filtration through a glass filter, and the filtrate was concentrated to give a residue, which was purified by column chromatography (3.5 g silica gel, MeOH/CHCl 3 ϭ1/5 as an eluent) to give roughly purified 5. This was further purified by gel filtration (Sephadex LH-20, 95 ml, MeOH as an eluent) to afford desulfonated sufamisterin (5) (2R,3R)-3-Hydroxy-2-hydroxymethyl-12-oxo-2-(2,2,2 
(2R,3R)-Desulfonated Sulfamisterin (6)
By the same reaction conditions as described for the preparation of 5 from 29a, compound 30a (90 mg, 0.174 mmol) was converted to (2R,3R)-desulfonated sulfamisterin (6) 
2-O-Benzyl-L-threitol (9b) (Enantiomer of 9a)
To a solution of dimethyl L-tartrate (30.0 g, 168 mmol) in
